Table 1. Self‐reported patient characteristics.
Trial drugs prior to TKI availability.
Abbreviations: CML, chronic myeloid leukemia; TKI, tyrosine kinase inhibitor.
Trial drugs prior to TKI availability.
Abbreviations: CML, chronic myeloid leukemia; TKI, tyrosine kinase inhibitor.